# Transcriptomic analysis of human primary T cells after short-term leucine-deprivation and evaluation of kinase GCN2’s role in regulating differential gene expression

**Authors:** Aurore Dougé, Gwendal Cueff, Céline Keime, Valérie Carraro, Céline Jousse, Paul Rouzaire, Alain Bruhat

PMC · DOI: 10.1371/journal.pone.0317505 · PLOS ONE · 2025-02-18

## TL;DR

This study explores how short-term leucine deprivation affects T cells and the role of the GCN2 kinase in gene expression changes, which could improve CAR-T cell therapy for cancer.

## Contribution

The study identifies GCN2-dependent gene expression changes in T cells after leucine deprivation, offering a novel strategy to enhance CAR-T cell efficacy.

## Key findings

- Leucine deprivation caused 3,431 genes to be differentially expressed in T cells.
- GCN2 inhibition showed that 59% of these genes depend on GCN2 activity.
- Enriched gene sets included TNFα signaling and interferon-γ response, while mTORC1 and oxidative phosphorylation were suppressed.

## Abstract

Chimeric Antigen Receptor T (CAR-T) cells offer a promising strategy for cancer treatment. These CAR-T cells are either autologous or allogeneic T cells that are genetically modified to express a chimeric antigen receptor targeting a specific tumor antigen. Ongoing research aims to optimize the CAR-T cell efficacy, including strategies to modulate their metabolism. One such approach involves inducing transgene expression by activating the GCN2 kinase signaling pathway through dietary deprivation of an essential amino acid. In this study, we investigated the general impact of a 6-hour leucine deprivation on primary activated human T cells using RNA-seq technology. Our analysis identified 3,431 differentially expressed genes between T cells cultured in regular medium and those cultured in leucine-deprived medium. Gene Set Enrichment Analysis revealed that “TNFα signaling via NFκB”, “interferon-γ response”, and “unfolded protein response” gene sets were positively enriched, while “mTORC1 signaling”, “Myc targets”, and “oxidative phosphorylation” gene sets were negatively enriched. To further evaluate the involvement of GCN2 kinase in regulating the differential gene expression during the 6-hour leucine deprivation, T cells were cultured with or without a GCN2 inhibitor. We found that 59% of the differentially expressed genes in our dataset were dependent on the kinase GCN2 (n = 2028), with 1,140 up-regulated and 888 down-regulated genes. These findings suggest a promising strategy to enhance CAR-T cell efficacy by combining short amino acid starvation with transient overexpression of a target gene.

## Linked entities

- **Genes:** EIF2AK4 (eukaryotic translation initiation factor 2 alpha kinase 4) [NCBI Gene 440275]
- **Chemicals:** leucine (PubChem CID 857)
- **Diseases:** cancer (MONDO:0004992)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, CXADRP1 (CXADR pseudogene 1) [NCBI Gene 653108] {aka CAR, CXADRP}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, EIF2AK4 (eukaryotic translation initiation factor 2 alpha kinase 4) [NCBI Gene 440275] {aka GCN2, PVOD2}
- **Diseases:** T (MESH:D001260), cancer (MESH:D009369)
- **Chemicals:** leucine (MESH:D007930)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11835326/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11835326/full.md

## References

25 references — full list in the complete paper: https://tomesphere.com/paper/PMC11835326/full.md

---
Source: https://tomesphere.com/paper/PMC11835326